COVID-19 Test to Treat

Data Information and Disclaimers The locations displayed above have received an order of Paxlovid or Lagevrio (molnupiravir) in the last two months and/or have reported availability of the oral antiviral medications within the last two weeks. Those sites that have not reported in the last two weeks display a notification with the site details, "Inventory has not been reported in the last 2 weeks. Please contact the provider to make sure the product is available."

All therapeutics identified in the locator must be used in alignment with the terms of the respective product’s EUA. Data displayed on this page is for informational purposes only. The data on this page is for locations with the oral antivirals Pfizer's Paxlovid and Merck's Lagevrio (molnupiravir). Visit COVID-19 Treatments and Therapeutics for more information on all treatment options.

The medication is provided at no cost. Some sites may charge for services not covered by insurance. Some sites may offer telehealth services. This website is intended for informational purposes only and does not serve as an endorsement or recommendation for use of any of the locations listed on the sites.

Clarification for DoD Facilities: Those individuals eligible for care in an MTF include Active Duty Service Members (ADSMs), covered beneficiaries enrolled in TRICARE Prime or Select, including TRICARE Reserve Select (TRS), TRICARE Retired Reserve (TRR) and TRICARE Young Adult (TYA) participants, TRICARE for Life beneficiaries, and individuals otherwise entitled by law to MTF care (e.g., regular retired members and their dependents who are not enrolled in TRICARE but who are otherwise eligible for MTF space-available care, certain foreign military members and their families registered in DEERS, and others).

Data and Resources

Field Value
accessLevel public
accrualPeriodicity R/P1D
bureauCode {009:15}
catalog_@context https://project-open-data.cio.gov/v1.1/schema/catalog.jsonld
catalog_@id https://healthdata.gov/data.json
catalog_conformsTo https://project-open-data.cio.gov/v1.1/schema
catalog_describedBy https://project-open-data.cio.gov/v1.1/schema/catalog.json
dataQuality true
identifier https://healthdata.gov/api/views/6m8a-tsjg
issued 2022-03-30
landingPage https://healthdata.gov/d/6m8a-tsjg
language {English}
modified 2022-07-28
programCode {009:028}
publisher U.S. Department of Health & Human Services
resource-type Dataset
source_datajson_identifier true
source_hash 024bba273483413920e31bd214ff7355568b2e30
source_schema_version 1.1
theme {Health}
Groups
  • AmeriGEOSS
  • National Provider
  • North America
Tags
  • amerigeo
  • amerigeoss
  • ckan
  • covid-19
  • covid-19-therapeutic
  • geo
  • geoss
  • hhs-covid-19
  • national
  • north-america
  • united-states
isopen False
license_id notspecified
license_title License not specified
maintainer HealthData.gov Team
maintainer_email HealthData@hhs.gov
metadata_created 2025-11-21T13:44:09.193731
metadata_modified 2025-11-21T13:44:09.193735
notes <b>Data Information and Disclaimers</b> The locations displayed above have received an order of Paxlovid or Lagevrio (molnupiravir) in the last two months and/or have reported availability of the oral antiviral medications within the last two weeks. Those sites that have not reported in the last two weeks display a notification with the site details, "Inventory has not been reported in the last 2 weeks. Please contact the provider to make sure the product is available." All therapeutics identified in the locator must be used in alignment with the terms of the respective product’s EUA. Data displayed on this page is for informational purposes only. The data on this page is for locations with the oral antivirals Pfizer's Paxlovid and Merck's Lagevrio (molnupiravir). Visit COVID-19 Treatments and Therapeutics for more information on all treatment options. The medication is provided at no cost. Some sites may charge for services not covered by insurance. Some sites may offer telehealth services. This website is intended for informational purposes only and does not serve as an endorsement or recommendation for use of any of the locations listed on the sites. Clarification for DoD Facilities: Those individuals eligible for care in an MTF include Active Duty Service Members (ADSMs), covered beneficiaries enrolled in TRICARE Prime or Select, including TRICARE Reserve Select (TRS), TRICARE Retired Reserve (TRR) and TRICARE Young Adult (TYA) participants, TRICARE for Life beneficiaries, and individuals otherwise entitled by law to MTF care (e.g., regular retired members and their dependents who are not enrolled in TRICARE but who are otherwise eligible for MTF space-available care, certain foreign military members and their families registered in DEERS, and others).
num_resources 4
num_tags 11
title COVID-19 Test to Treat